In the dynamic environment of Oregon’s K-12 schools, respiratory distress can strike without warning. For students with asthma, immediate access to a bronchodilator such as albuterol frequently determines whether they return promptly to learning or require emergency medical services. Notwithstanding the proven value of such medication, Oregon has yet to join the growing number of states that authorize schools to maintain undesignated stock albuterol inhalers for emergency administration to any student in need.
Current Oregon statute, primarily ORS 339.866, permits students with diagnosed asthma to self-carry and self-administer prescribed inhalers when supported by appropriate medical documentation and treatment plans. Schools may also store backup medication supplied by families. Although this policy advances student independence and responsibility, it leaves critical vulnerabilities unaddressed. Situations frequently arise in which a student’s personal inhaler is unavailable, forgotten, expired, lost, or when a first-time asthma episode occurs on school grounds. In these cases, staff currently lack legal authority to administer stock medication.
Several interrelated factors explain why stock albuterol legislation has not yet advanced in Oregon. Lawmakers may view the existing self-administration framework as adequate protection for most students. Recent legislative sessions have concentrated on other urgent school health priorities, including expanded options for epinephrine administration and increased access to naloxone. Additional concerns involving the establishment of standing orders, consistent staff training requirements, sustainable funding mechanisms, and comprehensive liability protections have further slowed momentum. Unlike certain other states that acted following highly visible incidents, Oregon has not encountered a widely publicized tragedy directly tied to the absence of stock rescue inhalers.
Across the nation, however, momentum continues to build. As of 2026, roughly twenty-four states plus the District of Columbia have enacted laws or guidelines permitting schools to stock albuterol under physician standing orders. Early-adopting programs have delivered compelling results. In Arizona’s Sunnyside Unified School District, the implementation of a stock albuterol initiative produced a 20 percent reduction in asthma-related 911 calls and a 40 percent decrease in ambulance transports within the first year of operation. These improvements highlight the capacity of stock inhalers to serve as an essential safety net without supplanting individualized asthma action plans.
School nurses in Oregon already provide expert leadership in asthma management. They develop detailed care plans, educate staff on symptom recognition and response, coordinate with families and medical providers, and address potential triggers during physical activities and field trips. State authorization for stock albuterol would substantially strengthen their ability to intervene decisively during emergencies.
Progress will demand strategic, collaborative advocacy. By partnering with the American Lung Association of Oregon, the Oregon School Nurses Association, the Oregon Pediatric Society, and local public health departments, stakeholders can develop and promote targeted legislation modeled after successful programs elsewhere. Pilot initiatives at the district level combined with systematic tracking of near-miss incidents would provide valuable supporting evidence.
Oregon has established itself as a leader in several areas of school-based emergency preparedness. Extending this commitment to encompass stock albuterol represents both a practical and ethical imperative. No student should face unnecessary risk when every breath matters. The time to close this preventable gap in student safety has arrived.